All-
Arena just received positive Phase 2 results or Olorinab, a nonopiode pain medication for abdominal pain. This is supposed to relieve symptoms of Cron’s Disease, ulcerative colitis, and irritable bowel syndrome.
I have not been able to find a TAM for this drug, and Phase 3 testing can go either way. This is not the reason to invest in ARNA, but it beats a poke in the eye.
bulwnkl
Are you full position on this stock? You have a great track record in the “binaries”.
I currently have about 3.5% in ARNA. Once I get a handle on Etrasimod (S1P Modulator) Phase 3 timing, I will probably buy some LEAPS.
A full position for me is 8% in most stocks. I will let my stocks run higher, but not add after that. For biotechs, this is my typical risk tolerance.
Best,
bulwnkl
For quick reference, here is the original posting from bulwnkl on Arena.
https://discussion.fool.com/binary-event-3-arena-pharmaceuticals…
-volfan84
self-assigned occasional cross-referencer